H.I.G. Capital Expands Its Footprint in Healthcare and Beyond

In recent months, H.I.G. Capital has been aggressively expanding its portfolio, focusing on strategic acquisitions within healthcare and adjacent sectors. This Miami-based investment firm, managing $65 billion, showcases its commitment to diversified growth.

A notable acquisition includes SkinCure Oncology, a leader in nonmelanoma skin cancer treatment using image-guided superficial radiation therapy. This aligns with H.I.G. Capital’s strategy to invest in innovative healthcare solutions that promise less invasive treatment options. With over 100,000 patients treated and partnerships with 500 physicians, SkinCure Oncology represents a robust addition to the firm’s healthcare investments.

But H.I.G. Capital isn’t limiting its focus to traditional healthcare. The firm has also invested in Naturalia Tantum, an Italian company specializing in organic personal care products. This acquisition underscores H.I.G. Capital’s interest in the booming natural and organic market, as consumers increasingly seek environmentally friendly alternatives.

In addition to acquisitions, H.I.G. Capital recently announced the sale of BIOVECTRA, a company it had owned since 2019, to Agilent Technologies for $925 million. This transaction highlights H.I.G. Capital’s ability to nurture companies towards significant growth and eventual high-value exits.

Furthermore, the acquisition of Action Elevator, alongside the purchase of Century Elevator, signals H.I.G. Capital’s strategic interest in infrastructure services, supporting industries like healthcare. This move strengthens their presence in the elevator maintenance market, particularly in the Mid-Atlantic region.

These calculated moves illustrate H.I.G. Capital’s proactive approach in capitalizing on diverse growth opportunities. With strategic investments in varied sectors—from cutting-edge cancer treatments to essential infrastructure services—the firm is poised to enhance its influence across multiple industries.

In recent months, H.I.G. Capital has been aggressively expanding its portfolio, focusing on strategic acquisitions within healthcare and adjacent sectors. This Miami-based investment firm, managing $65 billion, showcases its commitment to diversified growth. A notable acquisition includes SkinCure Oncology, a leader in nonmelanoma skin cancer treatment using image-guided superficial radiation therapy. This aligns with H.I.G.…